| Anthony R Rogerson, MD | |
|
515 22nd Ave, Monroe, WI 53566-1569 | |
| (608) 324-2000 | |
| Not Available |
| Full Name | Anthony R Rogerson |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 35 Years |
| Location | 515 22nd Ave, Monroe, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730273566 | NPI | - | NPPES |
| 390808509 | Other | CT GENERAL | |
| 390808509AL | Other | UNITY | |
| 40007132 | Other | MEDICARE RAILROAD | |
| 1004196 | Other | PHYSICIANS PLUS | |
| 10896 | Other | DEAN HEALTH PLAN | |
| 390808509 | Other | CIGNA | |
| 39080850961 | Other | UNITY | |
| 90002361 | Other | WEA INS | |
| 390808509 | Other | WPS | |
| 40015138 | Other | MEDICARE RAILROAD | |
| 32038900 | Other | HIRSP | |
| 32038900 | Medicaid | WI | |
| L54542 | Other | MEDICARE | |
| 690004890 | Other | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 036-092166 (Illinois) | Secondary |
| 207Y00000X | Otolaryngology | 35514 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Monroe Clinic | Monroe, WI | Hospital |
| Ssm Health St Mary's Hospital - Madison | Madison, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Monroe Clinic Inc | 3072425495 | 152 |
| The Monroe Clinic Inc | 3072425495 | 152 |
News Archive
ARTES Biotechnology, specialized in recombinant protein production and process development in microbial expression systems, started a development collaboration for two vaccines together with global biopharmaceutical company Crucell. Crucell is focused on the research & development, production and marketing of vaccines and antibodies against infectious disease worldwide.
nContact Surgical, Inc. reports with interest today the results of a physician-initiated study of the Convergent Procedure that, for the first time, measured the progress of persistent atrial fibrillation (AF) patients at one-year and six-month intervals. Results of the study, which were presented at the 2010 International Society of Minimally Invasive Cardiac Surgeons meeting in Berlin, Germany, indicated that after one year 80% of patients were in sinus rhythm and off anti-arrhythmic medication as a result of the closed chest, multi-disciplinary AF procedure.
Allergan plc, a leading global pharmaceutical company, and Rugen Therapeutics, a start-up biotechnology company focused on the development of novel treatments for unmet CNS disorders and funded by the F-Prime Biomedical Research Initiative, today announced that they have entered into an exclusive collaboration to support the discovery and development of novel therapies for Autism Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD).
While recent reports question whether fish oil supplements support heart health, UC Irvine scientists have found that the fatty acids they contain are vitally important to the developing brain.
› Verified 2 days ago
| Entity Name | The Monroe Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831254036 PECOS PAC ID: 3072425495 Enrollment ID: O20040112000130 |
News Archive
ARTES Biotechnology, specialized in recombinant protein production and process development in microbial expression systems, started a development collaboration for two vaccines together with global biopharmaceutical company Crucell. Crucell is focused on the research & development, production and marketing of vaccines and antibodies against infectious disease worldwide.
nContact Surgical, Inc. reports with interest today the results of a physician-initiated study of the Convergent Procedure that, for the first time, measured the progress of persistent atrial fibrillation (AF) patients at one-year and six-month intervals. Results of the study, which were presented at the 2010 International Society of Minimally Invasive Cardiac Surgeons meeting in Berlin, Germany, indicated that after one year 80% of patients were in sinus rhythm and off anti-arrhythmic medication as a result of the closed chest, multi-disciplinary AF procedure.
Allergan plc, a leading global pharmaceutical company, and Rugen Therapeutics, a start-up biotechnology company focused on the development of novel treatments for unmet CNS disorders and funded by the F-Prime Biomedical Research Initiative, today announced that they have entered into an exclusive collaboration to support the discovery and development of novel therapies for Autism Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD).
While recent reports question whether fish oil supplements support heart health, UC Irvine scientists have found that the fatty acids they contain are vitally important to the developing brain.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anthony R Rogerson, MD 515 22nd Ave, Monroe, WI 53566-1569 Ph: (608) 324-2000 | Anthony R Rogerson, MD 515 22nd Ave, Monroe, WI 53566-1569 Ph: (608) 324-2000 |
News Archive
ARTES Biotechnology, specialized in recombinant protein production and process development in microbial expression systems, started a development collaboration for two vaccines together with global biopharmaceutical company Crucell. Crucell is focused on the research & development, production and marketing of vaccines and antibodies against infectious disease worldwide.
nContact Surgical, Inc. reports with interest today the results of a physician-initiated study of the Convergent Procedure that, for the first time, measured the progress of persistent atrial fibrillation (AF) patients at one-year and six-month intervals. Results of the study, which were presented at the 2010 International Society of Minimally Invasive Cardiac Surgeons meeting in Berlin, Germany, indicated that after one year 80% of patients were in sinus rhythm and off anti-arrhythmic medication as a result of the closed chest, multi-disciplinary AF procedure.
Allergan plc, a leading global pharmaceutical company, and Rugen Therapeutics, a start-up biotechnology company focused on the development of novel treatments for unmet CNS disorders and funded by the F-Prime Biomedical Research Initiative, today announced that they have entered into an exclusive collaboration to support the discovery and development of novel therapies for Autism Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD).
While recent reports question whether fish oil supplements support heart health, UC Irvine scientists have found that the fatty acids they contain are vitally important to the developing brain.
› Verified 2 days ago